Literature DB >> 28915378

Revisiting murine models for atopic dermatitis and psoriasis with multipolar cytokine axes.

Kenji Kabashima1, Takashi Nomura2.   

Abstract

Atopic dermatitis (AD) and psoriasis are one of the common skin diseases. Animal models are a powerful tool to analyze these diseases, which are complicated by multiple cytokine pathways. However, many discrepancies between the human diseases and murine models have been noticed. Therefore, investigators should be aware of the differences between the murine AD models and human AD when translating murine data to human skin diseases. This review highlights the differences between the inflammatory profiles between murine models and human diseases focusing on AD and psoriasis.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28915378     DOI: 10.1016/j.coi.2017.08.010

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  4 in total

1.  DRM02, a novel phosphodiesterase-4 inhibitor with cutaneous anti-inflammatory activity.

Authors:  David W C Hunt; Iordanka A Ivanova; Lina Dagnino
Journal:  Tissue Barriers       Date:  2020-06-01

2.  TWEAK functions with TNF and IL-17 on keratinocytes and is a potential target for psoriasis therapy.

Authors:  Rinkesh K Gupta; Donald T Gracias; Daniela Salgado Figueroa; Haruka Miki; Jacqueline Miller; Kai Fung; Ferhat Ay; Linda Burkly; Michael Croft
Journal:  Sci Immunol       Date:  2021-11-19

3.  MicroRNA-17-92 cluster promotes the proliferation and the chemokine production of keratinocytes: implication for the pathogenesis of psoriasis.

Authors:  Weigang Zhang; Xiuli Yi; Yawen An; Sen Guo; Shuli Li; Pu Song; Yuqian Chang; Shaolong Zhang; Tianwen Gao; Gang Wang; Chunying Li
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

4.  Flightless I Alters the Inflammatory Response and Autoantibody Profile in an OVA-Induced Atopic Dermatitis Skin-Like Disease.

Authors:  Zlatko Kopecki; Natalie E Stevens; Heng T Chong; Gink N Yang; Allison J Cowin
Journal:  Front Immunol       Date:  2018-08-10       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.